4.7 Article

Post-discharge kidney function is associated with subsequent ten-year renal progression risk among survivors of acute kidney injury

期刊

KIDNEY INTERNATIONAL
卷 92, 期 2, 页码 -

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.kint.2017.02.019

关键词

acute kidney injury; chronic kidney disease; epidemiology; mortality; progression; prognosis

资金

  1. NHS Research Scotland, through NHS Grampian investment in the Grampian DaSH
  2. Clinical Research Training Fellowship from the Wellcome Trust [102729/Z/13/Z]
  3. Farr Institute of Health Informatics Research
  4. Arthritis Research UK
  5. British Heart Foundation
  6. Cancer Research UK
  7. Economic and Social Research Council
  8. Engineering and Physical Sciences Research Council
  9. Medical Research Council
  10. National Institute of Health Research
  11. National Institute for Social Care and Health Research (Welsh Assembly Government)
  12. Chief Scientist Office (Scottish Government Health Directorates)
  13. Wellcome Trust [MR/K007017/1]
  14. Medical Research Council [MR/K007017/1, MR/M501633/2, MR/M501633/1, MC_PC_13040] Funding Source: researchfish
  15. MRC [MR/M501633/2, MR/M501633/1, MR/K007017/1] Funding Source: UKRI

向作者/读者索取更多资源

The extent to which renal progression after acute kidney injury (AKI) arises from an initial step drop in kidney function (incomplete recovery), or from a long-term trajectory of subsequent decline, is unclear. This makes it challenging to plan or time post-discharge follow-up. This study of 14651 hospital survivors in 2003 (1966 with AKI, 12685 no AKI) separates incomplete recovery from subsequent renal decline by using the post-discharge estimated glomerular filtration rate (eGFR) rather than the pre-admission as a new reference point for determining subsequent renal outcomes. Outcomes were sustained 30% renal decline and de novo CKD stage 4, followed from 2003-2013. Death was a competing risk. Overall, death was more common than subsequent renal decline (37.5% vs 11.3%) and CKD stage 4 (4.5%). Overall, 25.7% of AKI patients had non-recovery. Subsequent renal decline was greater after AKI (vs no AKI) (14.8% vs 10.8%). Renal decline after AKI (vs no AKI) was greatest among those with higher post-discharge eGFRs with multivariable hazard ratios of 2.29 (1.88-2.78); 1.50 (1.13-2.00); 0.94 (0.68-1.32) and 0.95 (0.64-1.41) at eGFRs of 60 or more; 45-59; 30-44 and under 30, respectively. The excess risk after AKI persisted over ten years of study, irrespective of AKI severity, or post-episode proteinuria. Thus, even if post-discharge kidney function returns to normal, hospital admission with AKI is associated with increased renal progression that persists for up to ten years. Follow-up plans should avoid false reassurance when eGFR after AKI returns to normal.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Transplantation

Care processes and outcomes of deprivation across the clinical course of kidney disease: findings from a high-income country with universal healthcare

Simon Sawhney, Tom Blakeman, Dimitra Blana, Dwayne Boyers, Nick Fluck, Mintu Nath, Shona Methven, Magdalena Rzewuska, Corri Black

Summary: Inequities in kidney care exist even in high-income countries, with area-level deprivation having a greater impact in the earlier stages of the disease.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Urology & Nephrology

Consensus Recommendations for Sick Day Medication Guidance for People With Diabetes, Kidney, or Cardiovascular Disease: A Modified Delphi Process

Kaitlyn E. Watson, Kirnvir Dhaliwal, Sandra Robertshaw, Nancy Verdin, Eleanor Benterud, Nicole Lamont, Kelsea M. Drall, Kerry McBrien, Maoliosa Donald, Ross T. Tsuyuki, David J. T. Campbell, Neesh Pannu, Matthew T. James

Summary: This study aimed to establish recommendations for Sick day medication guidance (SDMG) through consensus among clinical experts. A multidisciplinary panel of 26 clinicians from 4 countries reached consensus on 42 specific recommendations, including triggers for SDMG, signs for urgent contact with healthcare providers, and self-management strategies for patients.

AMERICAN JOURNAL OF KIDNEY DISEASES (2023)

Article Medicine, General & Internal

Assessing Performance and Clinical Usefulness in Prediction Models With Survival Outcomes: Practical Guidance for Cox Proportional Hazards Models

David J. McLernon, Daniele Giardiello, Ben Van Calster, Laure Wynants, Nan van Geloven, Maarten van Smeden, Terry Therneau, Ewout W. Steyerberg, STRATOS Initiative

Summary: Risk prediction models need validation to assess their performance. This article focuses on evaluating predictions and improving clinical decision making using survival models based on Cox proportional hazards regression. The authors present a case study on breast cancer patients, where a Cox regression model is developed and validated for prediction of recurrence or death.

ANNALS OF INTERNAL MEDICINE (2023)

Article Obstetrics & Gynecology

Quality of clinical prediction models in in vitro fertilisation: Which covariates are really important to predict cumulative live birth and which models are best?

David J. McLernon, Siladitya Bhattacharya

Summary: The improvement in IVF cryopreservation techniques has led to an increase in elective single embryo transfer, reducing multiple pregnancy rates. Clinical prediction models are useful in estimating couples' chances of success and guiding future treatment. This review discusses different models for predicting cumulative live birth and recommends when and which models should be used.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study

Patrick B. Mark, Juan J. Carrero, Kunihiro Matsushita, Yingying Sang, Shoshana H. Ballew, Morgan E. Grams, Josef Coresh, Aditya Surapaneni, Nigel J. Brunskill, John Chalmers, Lili Chan, Alex R. Chang, Rajkumar Chinnadurai, Gabriel Chodick, Massimo Cirillo, Dick de Zeeuw, Marie Evans, Amit X. Garg, Orlando M. Gutierrez, Hiddo J. L. Heerspink, Gunnar H. Heine, William G. Herrington, Junichi Ishigami, Florian Kronenberg, Jun Young Lee, Adeera Levin, Rupert W. Major, Angharad Marks, Girish N. Nadkarni, David M. J. Naimark, Christoph Nowak, Mahboob Rahman, Charumathi Sabanayagam, Mark Sarnak, Simon Sawhney, Markus P. Schneider, Varda Shalev, Jung-Im Shin, Moneeza K. Siddiqui, Nikita Stempniewicz, Keiichi Sumida, Jose M. Valdivielso, Jan van den Brand, Angela Yee-Moon Wang, David C. Wheeler, Lihua Zhang, Frank L. J. Visseren, Benedicte Stengel

Summary: This study investigated the association between cardiovascular disease (CVD) and future risk of kidney failure with replacement therapy (KFRT). It found that both prevalent and incident CVD were strongly associated with KFRT risk, with incident HF showing the strongest association.

EUROPEAN HEART JOURNAL (2023)

Article Urology & Nephrology

The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts

Morgan E. Grams, Nigel J. Brunskill, Shoshana H. Ballew, Yingying Sang, Josef Coresh, Kunihiro Matsushita, Aditya Surapaneni, Samira Bell, Juan J. Carrero, Gabriel Chodick, Marie Evans, Hiddo J. L. Heerspink, Lesley A. Inker, Kunitoshi Iseki, Philip A. Kalra, H. Lester Kirchner, Brian J. Lee, Adeera Levin, Rupert W. Major, James Medcalf, Girish N. Nadkarni, David M. J. Naimark, Ana C. Ricardo, Simon Sawhney, Manish M. Sood, Natalie Staplin, Nikita Stempniewicz, Benedicte Stengel, Keiichi Sumida, Jamie P. Traynor, Jan van den Brand, Chi-Pang Wen, Mark Woodward, Jae Won Yang, Angela Yee-Moon Wang, Navdeep Tangri

Summary: The kidney failure risk equation (KFRE) accurately predicts kidney failure risk in people with GFR < 60 ml/min per 1.73 m(2) when using the CKD-EPI 2021 creatinine equation. Other modifications to the KFRE did not improve its performance.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Obstetrics & Gynecology

Early pregnancy outcomes of IVF cycles using donor versus partner sperm: analysis of 1 376 454 cycles recorded by the Human Fertilisation and Embryology Authority (1991-2016)

Christopher Allen, David McLernon, Sohinee Bhattacharya, Abha Maheshwari

Summary: Pregnancies conceived with donor sperm have a lower odds of early pregnancy loss and ectopic pregnancy compared to pregnancies conceived with partner sperm.

HUMAN REPRODUCTION (2023)

Article Multidisciplinary Sciences

STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: A structured protocol

Denise Forshaw, Emma C. Wall, Gordon Prescott, Hakim-Moulay Dehbi, Angela Green, Emily Attree, Lyth Hismeh, William D. Strain, Michael G. Crooks, Caroline Watkins, Chris Robson, Rajarshi Banerjee, Paula Lorgelly, Melissa Heightman, Amitava Banerjee

Summary: This study is a multi-centre, cluster-randomised clinical trial evaluating the effectiveness of an integrated care pathway for long COVID (LC). The trial includes medical imaging examinations, a digital rehabilitation platform, and a drug trial. It is being conducted in 6-10 LC clinics in the UK and aims to assess the reduction in fatigue and other physical, psychological, and functional outcomes in adults with LC after 3 months of the pathway of care.

PLOS ONE (2023)

Article Urology & Nephrology

Prediction of major postoperative events after non-cardiac surgery for people with kidney failure: derivation and internal validation of risk models

Tyrone G. Harrison, Brenda R. Hemmelgarn, Matthew T. James, Simon Sawhney, Braden J. Manns, Marcello Tonelli, Shannon M. Ruzycki, Kelly B. Zarnke, Todd A. Wilson, Deirdre McCaughey, Paul E. Ronksley

Summary: This study aimed to develop and validate risk prediction models for patients with kidney failure undergoing non-cardiac surgery. The models including comorbidities and laboratory variables showed improved accuracy in risk stratification and provided the greatest potential net benefit for guiding perioperative decisions.

BMC NEPHROLOGY (2023)

Review Urology & Nephrology

Inequities in kidney health and kidney care

Raymond Vanholder, Lieven Annemans, Marion Braks, Edwina A. Brown, Priya Pais, Tanjala S. Purnell, Simon Sawhney, Nicole Scholes-Robertson, Benedicte Stengel, Elliot K. Tannor, Vladimir Tesar, Arjan van der Tol, Valerie A. Luyckx

Summary: Kidney disease risk and outcomes are strongly influenced by inequities across its clinical course, including insufficient investment and social/structural inequities. Access to affordable kidney care is highly unequal, leading to financial hardship for vulnerable populations. Advocacy and leadership by the nephrology community are crucial to address and dismantle these inequities.

NATURE REVIEWS NEPHROLOGY (2023)

Article Transplantation

Recovery of kidney function after acute kidney disease-a multi-cohort analysis

Simon Sawhney, William Ball, Samira Bell, Corri Black, Christian F. Christiansen, Uffe Heide-Jorgensen, Simon K. Jensen, Emilie Lambourg, Paul E. Ronksley, Zhi Tan, Marcello Tonelli, Matthew T. James

Summary: A federated analysis of four population-based cohorts from Canada, Denmark and Scotland was conducted to evaluate kidney function recovery after AKI and AKD. Results at 1 year were consistent across cohorts, with differences in outcomes associated with AKD by age, sex, and comorbidities. Older males were more likely to die, while younger females were less likely to recover.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Obstetrics & Gynecology

ESHRE good practice recommendations on recurrent implantation failure†

D. Cimadomo, M. J. de los Santos, G. Griesinger, G. Lainas, N. Le Clef, D. J. McLernon, D. Montjean, B. Toth, N. Vermeulen, N. Macklon

Summary: This article provides the first ESHRE good practice recommendations for defining and managing recurrent implantation failure (RIF) in patients undergoing ART. RIF is a challenge in the ART clinic, with numerous investigations and interventions offered and applied without clear biological rationale or evidence of benefit. The recommendations include investigating causes and contributing factors of RIF, as well as improving the chances of a successful pregnancy.

HUMAN REPRODUCTION OPEN (2023)

Article Obstetrics & Gynecology

A comparison of perinatal outcomes following fresh blastocyst or cleavage stage embryo transfer in singletons and twins and between singleton siblings

Edwin-Amalraj Raja, Siladitya Bhattacharya, Abha Maheshwari, David J. McLernon

Summary: This study compared perinatal outcomes of fresh blastocyst transfer and fresh cleavage stage embryo transfer in singletons, twins, and singleton siblings. The results showed that singleton babies born following fresh blastocyst transfer had a lower risk of being small for gestational age (SGA) or having a congenital anomaly compared to those born following fresh cleavage stage transfer. However, singleton babies born following fresh blastocyst transfer were at a higher risk of being large for gestational age (LGA). Twins resulting from fresh blastocyst transfer were also at a slightly higher risk of preterm birth. These findings highlight the potential benefits and risks associated with blastocyst stage transfer.

HUMAN REPRODUCTION OPEN (2023)

Article Clinical Neurology

Incidence and risk factors of institutionalisation in Parkinson's disease and atypical parkinsonism

Yan Li, David J. McLernon, Carl E. Counsell, Angus D. Macleod

Summary: This study aimed to investigate the incidence and risk factors for institutionalisation in Parkinson's disease (PD) and atypical parkinsonism (AP). The study found that institutionalisation was more frequent in AP compared to PD and controls. Age, poorer cognition, and more-severe parkinsonian impairment were independent predictors of institutionalisation.

PARKINSONISM & RELATED DISORDERS (2024)

Article Cardiac & Cardiovascular Systems

Using the Revised Cardiac Risk Index to Predict Major Postoperative Events for People With Kidney Failure: An External Validation and Update

Tyrone G. Harrison, Brenda R. Hemmelgarn, Matthew T. James, Simon Sawhney, Ngan N. Lam, Shannon M. Ruzycki, Todd A. Wilson, Paul E. Ronksley

Summary: The revised cardiac risk index (RCRI) performs poorly and overestimates risk in the population with kidney failure, indicating the need for limitations on its use. There is a need for novel perioperative models for this population.

CJC OPEN (2022)

暂无数据